体外毒性試験法の世界市場

体外毒性試験法の世界市場は2030年までに52億米ドルに到達

2024年に22億米ドルと推定される体外毒性試験法の世界市場は、2024年から2030年にかけてCAGR 15.9%で成長し、2030年には52億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである細胞アッセイ法は、CAGR18.3%を記録し、分析期間終了時には23億米ドルに達すると予測されます。生細胞法セグメントの成長率は、分析期間中CAGR13.6％と推定されます。

米国市場は5億8,660万米ドルと推定、中国はCAGR21.4%で成長予測

米国の体外毒性試験法市場は、2024年に5億8,660万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに12億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは21.4%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ11.5％と14.4％と予測されています。欧州では、ドイツがCAGR約12.7%で成長すると予測されています。

世界の体外毒性試験法市場- 主要動向と促進要因のまとめ

体外毒性試験法が現代の安全性テストの中心になりつつある理由とは？

体外毒性試験法は、動物実験に関連する倫理的かつ実用的な課題を伴わずに、化学物質、医薬品、消費者製品の毒性学的影響に関する詳細な洞察を提供する能力により、現代の安全性評価戦略の重要な要素として浮上してきました。これらのアッセイは、培養細胞、組織、または特定の臓器機能をモデル化するために再構築されたヒト生物学的システムを用いており、研究者は制御された実験室環境で細胞毒性、遺伝毒性、酸化ストレス、およびその他の細胞応答を評価することができます。代替試験モデルに対する需要の高まりは、欧州連合（EU）による化粧品の動物実験禁止や、研究における動物使用の削減を提唱する世界の運動のような、より厳格な規制の枠組みによってもたらされています。in-vitroアッセイは、in-vivoモデルと比較して、迅速なターンアラウンド、低コスト、スケーラビリティの向上を実現し、製薬会社、化学メーカー、規制機関を問わず魅力的なものとなっています。また、ハイスループット・プラットフォームを使って何千もの化合物を迅速にスクリーニングする能力は、医薬品開発プロセスを加速し、産業規模での化学的安全性評価をサポートします。さらに、これらのアッセイにより、特定の分子経路を単離することで、用量反応関係や作用機序をより深く理解することができます。製造される物質が複雑化し、安全規制が強化されるにつれて、in-vitro毒性学は、さまざまな産業における初期段階のスクリーニング、リスク評価、規制遵守の取り組みにおいて不可欠なものとなりつつあります。

技術はどのように試験管内毒性学的手法の精度と有用性を高めているのか？

技術革新は、生物学的関連性、感度、予測力を高めることにより、体外毒性試験法の性能と適用性に革命をもたらしています。主要な進歩の一つは、従来の二次元モデルよりもヒト組織の構造的・機能的複雑性をより正確に模倣した三次元細胞培養や臓器オンチップシステムの使用です。これらの高度なプラットフォームは、組織特異的な反応や長期的な毒性効果の研究を可能にし、物質がヒトの生物学とどのように相互作用するかを、より現実的に評価することができます。マイクロ流体工学との統合により、生理的環境を再現する動的なフロー条件が可能になり、アッセイの精度がさらに向上します。ハイコンテント・スクリーニング技術は、自動化されたイメージングとデータ解析により、形態、生存率、タンパク質発現など、複数の細胞パラメーターを同時に解析することを可能にしています。人工知能と機械学習アルゴリズムは、膨大な量のアッセイデータを処理し、毒性パターンを特定し、精度を高めて結果を予測するために導入されています。さらに、ゲノミクス、トランスクリプトミクス、メタボロミクスなどのオミクス技術を取り入れることで、経路レベルの洞察を明らかにし、バイオマーカー探索をサポートするメカニズム論的毒性学研究が可能になります。アッセイの標準化とバリデーションの改善により、試験室や地域を超えて再現性と妥当性を評価する枠組みが整備され、規制当局の受け入れも促進されています。このような技術的飛躍は、試験管内毒性学の科学的能力を拡大するだけでなく、最新の毒性学的評価と製品開発の要としての役割を強化しています。

規制および業界の要求は、どのように試験管内毒性試験情勢を形成しているか？

規制政策と産業界のニーズの影響力の高まりが、体外毒性試験法の方向性と採用を大きく形成しています。世界中の政府や規制機関は、化学物質の登録、医薬品の承認、製品の安全性評価のために、非動物実験データを要求するようになってきています。欧州医薬品庁（EMA）、米国環境保護庁（EPA）、経済協力開発機構（OECD）などの機関は、有効なin-vitro試験ガイドラインを積極的に支持しており、科学界における信頼の構築と承認プロセスの合理化に貢献しています。特に医薬品、化粧品、農薬などの業界関係者は、規制当局の期待に沿ったアッセイ開発、自動化プラットフォーム、統合データシステムに投資することで、こうしたシフトに対応しています。動物福祉をめぐる社会的監視の高まりも、企業により透明で倫理的な試験方法の採用を促しています。さらに、個別化医療の推進により、個体差を考慮したより精密な毒性スクリーニングツールが必要とされ、ヒトに関連した体外モデルの必要性がさらに高まっています。新興企業や研究開発は、規制当局と協力し、法域を超えたアッセイの一貫性と相互運用性を確保する標準を共同開発しています。多くのセクターにおいて、試験管内毒性学は現在、製品開発パイプラインの早い段階で組み込まれ、後期段階での失敗を減らし、安全性プロファイルを強化し、環境衛生と安全性のベンチマークを満たしています。規制当局、消費者、科学的進歩からのこれらの交差する圧力は、企業の安全性試験への取り組み方を変化させ、体外毒性試験法を責任あるイノベーションと世界のコンプライアンスに不可欠なツールとして確固たるものにしています。

体外毒性試験法市場の世界的成長の原動力は？

体外毒性試験法市場の成長は、規制改革、科学的進歩、産業界の需要、より倫理的で効果的な試験方法に対する社会的期待の組み合わせによってもたらされています。主要な成長要因の一つは、動物実験を削減または廃止しようという世界の機運であり、特に化粧品や消費者向け健康製品において、公開会社による圧力や法規制が、有効なin-vitro代替法への移行を促しています。同時に、製薬やバイオテクノロジーの分野では、初期段階の開発リスクを軽減し、膨大な化学物質ライブラリーをよりコスト効率よく迅速にスクリーニングするために、in-vitroアッセイを利用する動きが加速しています。また、環境毒性への懸念や化学物質曝露モニタリングの高まりも、産業界や政府機関におけるin-vitro試験の需要を拡大しています。細胞モデリング、人工知能、データ統合における技術の飛躍的進歩は、科学的基準と規制基準の両方を満たす、より正確でスケーラブルかつ再現性の高い試験プラットフォームをさらに可能にしています。新興経済国では、研究インフラへの投資の増加、医薬品研究開発費の増加、研究所の能力向上が、体外検査技術の幅広い採用に寄与しています。さらに、学術界、産業界、公衆衛生機関の連携により、内分泌かく乱作用や慢性毒性などの複雑なエンドポイントに対応できる次世代毒性学モデルやプラットフォームの開発が促進されています。技術、政策、倫理の交差点が進化し続ける中、世界の体外毒性試験法市場は、多様な産業や用途に対して、より安全で、より迅速で、よりヒトに関連した試験方法を提供し、継続的な拡大の態勢を整えています。

セグメント

方法（細胞アッセイ法、生細胞法、固定細胞法、その他の方法）、検査タイプ（大麻検査タイプ、ニコチン検査タイプ）、技術（3D細胞培養技術、質量分析技術、フローサイトメトリー技術、その他の技術）、用途（遺伝毒性検査用途、発がん性検査用途、細胞毒性検査用途、変異原性検査用途、その他の用途）

調査対象企業の例

• Abcam plc
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• BioIVT
• BioVision Inc.
• Charles River Laboratories
• Creative Bioarray
• Cyprotex（Evotec Group）
• Eurofins Scientific
• GE Healthcare Life Sciences
• Gentronix Ltd
• HemoGenix Inc.
• Merck KGaA（MilliporeSigma）
• PerkinElmer Inc.
• Promega Corporation
• QIAGEN N.V.
• Sekisui XenoTech LLC
• SGS SA
• Thermo Fisher Scientific
• Toxikon Corporation

AIインテグレイションズ

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global In-Vitro Toxicology Assays Market to Reach US$5.2 Billion by 2030

The global market for In-Vitro Toxicology Assays estimated at US$2.2 Billion in the year 2024, is expected to reach US$5.2 Billion by 2030, growing at a CAGR of 15.9% over the analysis period 2024-2030. Cellular Assay Method, one of the segments analyzed in the report, is expected to record a 18.3% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Live Cells Method segment is estimated at 13.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$586.6 Million While China is Forecast to Grow at 21.4% CAGR

The In-Vitro Toxicology Assays market in the U.S. is estimated at US$586.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.2 Billion by the year 2030 trailing a CAGR of 21.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 14.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.7% CAGR.

Global In-Vitro Toxicology Assays Market - Key Trends & Drivers Summarized

Why Are In-Vitro Toxicology Assays Becoming Central to Modern Safety Testing?

In-vitro toxicology assays have emerged as a vital component of contemporary safety assessment strategies, largely due to their ability to provide detailed insights into the toxicological effects of chemical substances, pharmaceuticals, and consumer products without the ethical and practical challenges associated with animal testing. These assays use cultured cells, tissues, or reconstructed human biological systems to model specific organ functions, allowing researchers to assess cytotoxicity, genotoxicity, oxidative stress, and other cellular responses in a controlled laboratory setting. The growing demand for alternative testing models is being driven by stricter regulatory frameworks, such as the European Union’s ban on animal testing for cosmetics and global movements advocating for the reduction of animal use in research. In-vitro assays offer faster turnaround, lower costs, and increased scalability compared to in-vivo models, making them attractive to pharmaceutical companies, chemical manufacturers, and regulatory bodies alike. Their ability to screen thousands of compounds rapidly using high-throughput platforms also accelerates the drug development process and supports chemical safety evaluation at an industrial scale. Additionally, these assays enable a deeper understanding of dose-response relationships and mechanisms of action by isolating specific molecular pathways. As the complexity of manufactured substances grows and safety regulations tighten, in-vitro toxicology is becoming indispensable in early-stage screening, risk assessment, and regulatory compliance efforts across a variety of industries.

How Is Technology Advancing the Accuracy and Utility of In-Vitro Toxicology Methods?

Technological innovation is revolutionizing the performance and applicability of in-vitro toxicology assays by enhancing their biological relevance, sensitivity, and predictive power. One major advancement is the use of 3D cell cultures and organ-on-chip systems that mimic the structural and functional complexity of human tissues more accurately than traditional two-dimensional models. These advanced platforms enable the study of tissue-specific responses and long-term toxicity effects, providing a more realistic assessment of how substances interact with human biology. Integration with microfluidics allows for dynamic flow conditions that replicate physiological environments, further improving assay precision. High-content screening technologies are making it possible to analyze multiple cellular parameters simultaneously, such as morphology, viability, and protein expression, through automated imaging and data analytics. Artificial intelligence and machine learning algorithms are being deployed to process vast amounts of assay data, identify toxicity patterns, and predict outcomes with increasing accuracy. Additionally, the incorporation of omics technologies, including genomics, transcriptomics, and metabolomics, enables mechanistic toxicology studies that uncover pathway-level insights and support biomarker discovery. Improvements in assay standardization and validation are also facilitating regulatory acceptance, with frameworks now in place to assess reproducibility and relevance across laboratories and geographies. These technological leaps are not only expanding the scientific capabilities of in-vitro toxicology but also reinforcing its role as a cornerstone of modern toxicological assessment and product development.

How Are Regulatory and Industry Demands Shaping the In-Vitro Toxicology Assay Landscape?

The growing influence of regulatory policies and industry needs is significantly shaping the direction and adoption of in-vitro toxicology assays. Governments and regulatory agencies across the globe are increasingly requiring non-animal testing data for chemical registration, drug approval, and product safety evaluation. Agencies such as the European Medicines Agency (EMA), the U.S. Environmental Protection Agency (EPA), and the Organization for Economic Cooperation and Development (OECD) are actively endorsing validated in-vitro test guidelines, which are helping to build trust in the scientific community and streamline approval processes. Industry players, especially in pharmaceuticals, cosmetics, and agrochemicals, are responding to these shifts by investing in assay development, automation platforms, and integrated data systems that align with regulatory expectations. The increased public scrutiny surrounding animal welfare is also pushing corporations to adopt more transparent and ethical testing practices. Moreover, the drive toward personalized medicine is requiring more precise toxicity screening tools that account for individual variability, further strengthening the case for human-relevant in-vitro models. Startups and research organizations are collaborating with regulatory bodies to co-develop standards that ensure assay consistency and interoperability across jurisdictions. In many sectors, in-vitro toxicology is now being incorporated early in the product development pipeline to reduce late-stage failures, enhance safety profiles, and meet environmental health and safety benchmarks. These intersecting pressures from regulators, consumers, and scientific advancements are reshaping how companies approach safety testing, cementing in-vitro toxicology assays as essential tools for responsible innovation and global compliance.

What Is Fueling the Global Growth of the In-Vitro Toxicology Assays Market?

The growth in the in-vitro toxicology assays market is driven by a combination of regulatory reform, scientific advancement, industrial demand, and societal expectations for more ethical and effective testing methods. One of the key growth drivers is the global momentum toward reducing or eliminating animal testing, particularly in cosmetics and consumer health products, where public pressure and legislation are prompting companies to shift toward validated in-vitro alternatives. Simultaneously, the pharmaceutical and biotechnology sectors are increasingly using in-vitro assays to de-risk early-stage development and screen vast chemical libraries more cost-effectively and rapidly. The rise in environmental toxicity concerns and chemical exposure monitoring is also expanding demand for in-vitro testing in industrial and governmental contexts. Technological breakthroughs in cell modeling, artificial intelligence, and data integration are further enabling more accurate, scalable, and reproducible testing platforms that meet both scientific and regulatory standards. In emerging economies, increased investment in research infrastructure, rising pharmaceutical R&D spending, and improvements in laboratory capacity are contributing to the broader adoption of in-vitro testing technologies. Furthermore, collaborations between academia, industry, and public health agencies are fostering the development of next-generation toxicology models and platforms that can address complex endpoints such as endocrine disruption and chronic toxicity. As the intersection of technology, policy, and ethics continues to evolve, the global in-vitro toxicology assays market is poised for continued expansion, offering safer, faster, and more human-relevant testing methods for a diverse range of industries and applications.

SCOPE OF STUDY:

The report analyzes the In-Vitro Toxicology Assays market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Method (Cellular Assay Method, Live Cells Method, Fixed Cells Method, Other Methods); Test Type (Cannabis Testing Type, Nicotine Testing Type); Technology (3D Cell Culture Technology, Mass Spectrometry Technology, Flow Cytometry Technology, Other Technologies); Application (Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Abcam plc
• Agilent Technologies Inc.
• Bio-Rad Laboratories Inc.
• BioIVT
• BioVision Inc.
• Charles River Laboratories
• Creative Bioarray
• Cyprotex (Evotec Group)
• Eurofins Scientific
• GE Healthcare Life Sciences
• Gentronix Ltd
• HemoGenix Inc.
• Merck KGaA (MilliporeSigma)
• PerkinElmer Inc.
• Promega Corporation
• QIAGEN N.V.
• Sekisui XenoTech LLC
• SGS SA
• Thermo Fisher Scientific
• Toxikon Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • In-Vitro Toxicology Assays - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Shift Away from Animal Testing Throws the Spotlight on In-Vitro Toxicology Assays as Ethical and Scalable Alternatives
  • Global Regulatory Push for Non-Animal Safety Assessments Propels Demand for Validated In-Vitro Assay Platforms
  • Here's the Story: Rising R&D in Cosmetics, Chemicals, and Pharmaceuticals Strengthens the Business Case for High-Throughput In-Vitro Models
  • Here's How Advancements in 3D Cell Culture and Organoids Are Improving Physiological Relevance in Toxicology Assays
  • Increasing Emphasis on Human-Relevant Data Accelerates the Shift Toward Primary Cell and Stem Cell-Derived In-Vitro Systems
  • Growth in Environmental and Food Safety Testing Fuels Adoption of In-Vitro Assays for Screening of Low-Level Contaminants
  • Here's How Automation and Microfluidics Are Enabling High-Throughput, Cost-Efficient Toxicity Testing Pipelines
  • Integration of AI and Predictive Modeling Tools Enhances Data Interpretation and Mechanistic Insight in In-Vitro Studies
  • Rising Complexity of Chemical Formulations Drives Demand for Multiparametric and Multi-Endpoint In-Vitro Testing Strategies
  • Here's How In-Vitro Assays Are Supporting Early De-Risking and Lead Optimization in Drug Development Pipelines
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World In-Vitro Toxicology Assays Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for In-Vitro Toxicology Assays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for In-Vitro Toxicology Assays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Cellular Assay Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Cellular Assay Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for Cellular Assay Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Live Cells Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Live Cells Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Live Cells Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Fixed Cells Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Fixed Cells Method by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Fixed Cells Method by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Other Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Other Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for 3D Cell Culture Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for 3D Cell Culture Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for 3D Cell Culture Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Mass Spectrometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Mass Spectrometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Mass Spectrometry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Flow Cytometry Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Flow Cytometry Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Genetic Toxicity Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Genetic Toxicity Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 31: World 16-Year Perspective for Genetic Toxicity Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Carcinogenicity Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Carcinogenicity Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 34: World 16-Year Perspective for Carcinogenicity Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Cytotoxicity Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Cytotoxicity Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 37: World 16-Year Perspective for Cytotoxicity Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Mutagenicity Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Mutagenicity Testing Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 40: World 16-Year Perspective for Mutagenicity Testing Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 43: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 44: World Recent Past, Current & Future Analysis for Cannabis Testing Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 45: World Historic Review for Cannabis Testing Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 46: World 16-Year Perspective for Cannabis Testing Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 47: World Recent Past, Current & Future Analysis for Nicotine Testing Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 48: World Historic Review for Nicotine Testing Type by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 49: World 16-Year Perspective for Nicotine Testing Type by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 50: USA Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 52: USA 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 55: USA 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 56: USA Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: USA Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 58: USA 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 59: USA Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: USA Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 61: USA 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• CANADA
  • TABLE 62: Canada Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 64: Canada 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 65: Canada Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Canada Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 67: Canada 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 68: Canada Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Canada Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 70: Canada 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 71: Canada Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Canada Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 73: Canada 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• JAPAN
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 74: Japan Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Japan Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 76: Japan 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 77: Japan Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: Japan Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 79: Japan 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 80: Japan Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Japan Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 82: Japan 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 83: Japan Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Japan Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 85: Japan 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• CHINA
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 86: China Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: China Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 88: China 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 89: China Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: China Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 91: China 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 92: China Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: China Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 94: China 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 95: China Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: China Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 97: China 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• EUROPE
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 98: Europe Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 99: Europe Historic Review for In-Vitro Toxicology Assays by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 100: Europe 16-Year Perspective for In-Vitro Toxicology Assays by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
  • TABLE 101: Europe Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Europe Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 103: Europe 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 104: Europe Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Europe Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 106: Europe 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 107: Europe Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Europe Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 109: Europe 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 110: Europe Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Europe Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 112: Europe 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• FRANCE
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 113: France Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: France Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 115: France 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 116: France Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: France Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 118: France 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 119: France Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: France Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 121: France 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 122: France Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: France Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 124: France 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• GERMANY
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 125: Germany Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Germany Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 127: Germany 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 128: Germany Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Germany Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 130: Germany 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 131: Germany Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Germany Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 133: Germany 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 134: Germany Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Germany Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 136: Germany 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• ITALY
  • TABLE 137: Italy Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Italy Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 139: Italy 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 140: Italy Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Italy Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 142: Italy 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 143: Italy Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Italy Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 145: Italy 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 146: Italy Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Italy Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 148: Italy 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• UNITED KINGDOM
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 149: UK Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: UK Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 151: UK 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 152: UK Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: UK Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 154: UK 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 155: UK Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: UK Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 157: UK 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 158: UK Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: UK Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 160: UK 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• SPAIN
  • TABLE 161: Spain Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Spain Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 163: Spain 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 164: Spain Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Spain Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 166: Spain 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 167: Spain Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Spain Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 169: Spain 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 170: Spain Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Spain Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 172: Spain 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• RUSSIA
  • TABLE 173: Russia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Russia Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 175: Russia 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 176: Russia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Russia Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 178: Russia 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 179: Russia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Russia Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 181: Russia 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 182: Russia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Russia Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 184: Russia 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• REST OF EUROPE
  • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Rest of Europe Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 187: Rest of Europe 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 188: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Rest of Europe Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 190: Rest of Europe 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Europe Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 193: Rest of Europe 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Europe Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 196: Rest of Europe 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• ASIA-PACIFIC
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 198: Asia-Pacific Historic Review for In-Vitro Toxicology Assays by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 199: Asia-Pacific 16-Year Perspective for In-Vitro Toxicology Assays by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
  • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Asia-Pacific Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 202: Asia-Pacific 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Asia-Pacific Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 205: Asia-Pacific 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Asia-Pacific Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 208: Asia-Pacific 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Asia-Pacific Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 211: Asia-Pacific 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• AUSTRALIA
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 212: Australia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Australia Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 214: Australia 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 215: Australia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Australia Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 217: Australia 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 218: Australia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Australia Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 220: Australia 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 221: Australia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Australia Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 223: Australia 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• INDIA
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 224: India Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: India Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 226: India 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 227: India Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: India Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 229: India 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 230: India Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: India Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 232: India 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 233: India Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: India Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 235: India 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• SOUTH KOREA
  • TABLE 236: South Korea Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: South Korea Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 238: South Korea 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 239: South Korea Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: South Korea Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 241: South Korea 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 242: South Korea Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: South Korea Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 244: South Korea 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 245: South Korea Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 246: South Korea Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 247: South Korea 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Asia-Pacific Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 250: Rest of Asia-Pacific 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 251: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Asia-Pacific Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 253: Rest of Asia-Pacific 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Rest of Asia-Pacific Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 256: Rest of Asia-Pacific 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Rest of Asia-Pacific Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 259: Rest of Asia-Pacific 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• LATIN AMERICA
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 260: Latin America Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 261: Latin America Historic Review for In-Vitro Toxicology Assays by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 262: Latin America 16-Year Perspective for In-Vitro Toxicology Assays by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
  • TABLE 263: Latin America Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Latin America Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 265: Latin America 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 266: Latin America Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Latin America Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 268: Latin America 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 269: Latin America Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Latin America Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 271: Latin America 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 272: Latin America Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Latin America Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 274: Latin America 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• ARGENTINA
  • TABLE 275: Argentina Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Argentina Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 277: Argentina 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 278: Argentina Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Argentina Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 280: Argentina 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 281: Argentina Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Argentina Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 283: Argentina 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 284: Argentina Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Argentina Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 286: Argentina 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• BRAZIL
  • TABLE 287: Brazil Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Brazil Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 289: Brazil 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 290: Brazil Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Brazil Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 292: Brazil 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 293: Brazil Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Brazil Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 295: Brazil 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 296: Brazil Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Brazil Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 298: Brazil 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• MEXICO
  • TABLE 299: Mexico Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Mexico Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 301: Mexico 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 302: Mexico Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Mexico Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 304: Mexico 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 305: Mexico Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Mexico Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 307: Mexico 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 308: Mexico Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Mexico Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 310: Mexico 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Rest of Latin America Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 313: Rest of Latin America 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 314: Rest of Latin America Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Rest of Latin America Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 316: Rest of Latin America 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Rest of Latin America Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 319: Rest of Latin America 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Rest of Latin America Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 322: Rest of Latin America 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• MIDDLE EAST
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 323: Middle East Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 324: Middle East Historic Review for In-Vitro Toxicology Assays by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 325: Middle East 16-Year Perspective for In-Vitro Toxicology Assays by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
  • TABLE 326: Middle East Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Middle East Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 328: Middle East 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 329: Middle East Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Middle East Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 331: Middle East 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 332: Middle East Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Middle East Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 334: Middle East 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 335: Middle East Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Middle East Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 337: Middle East 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• IRAN
  • TABLE 338: Iran Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Iran Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 340: Iran 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 341: Iran Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Iran Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 343: Iran 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 344: Iran Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Iran Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 346: Iran 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 347: Iran Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Iran Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 349: Iran 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• ISRAEL
  • TABLE 350: Israel Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Israel Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 352: Israel 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 353: Israel Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Israel Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 355: Israel 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 356: Israel Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Israel Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 358: Israel 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 359: Israel Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: Israel Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 361: Israel 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• SAUDI ARABIA
  • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: Saudi Arabia Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 364: Saudi Arabia 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 365: Saudi Arabia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: Saudi Arabia Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 367: Saudi Arabia 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: Saudi Arabia Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 370: Saudi Arabia 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Saudi Arabia Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 373: Saudi Arabia 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 374: UAE Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: UAE Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 376: UAE 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 377: UAE Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: UAE Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 379: UAE 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 380: UAE Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: UAE Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 382: UAE 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 383: UAE Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: UAE Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 385: UAE 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Rest of Middle East Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 388: Rest of Middle East 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 389: Rest of Middle East Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Rest of Middle East Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 391: Rest of Middle East 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Rest of Middle East Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 394: Rest of Middle East 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 396: Rest of Middle East Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 397: Rest of Middle East 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030
• AFRICA
  • In-Vitro Toxicology Assays Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 398: Africa Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 399: Africa Historic Review for In-Vitro Toxicology Assays by Method - Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 400: Africa 16-Year Perspective for In-Vitro Toxicology Assays by Method - Percentage Breakdown of Value Sales for Cellular Assay Method, Live Cells Method, Fixed Cells Method and Other Methods for the Years 2014, 2025 & 2030
  • TABLE 401: Africa Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 402: Africa Historic Review for In-Vitro Toxicology Assays by Technology - Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 403: Africa 16-Year Perspective for In-Vitro Toxicology Assays by Technology - Percentage Breakdown of Value Sales for Other Technologies, 3D Cell Culture Technology, Mass Spectrometry Technology and Flow Cytometry Technology for the Years 2014, 2025 & 2030
  • TABLE 404: Africa Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 405: Africa Historic Review for In-Vitro Toxicology Assays by Application - Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 406: Africa 16-Year Perspective for In-Vitro Toxicology Assays by Application - Percentage Breakdown of Value Sales for Genetic Toxicity Testing Application, Carcinogenicity Testing Application, Cytotoxicity Testing Application, Mutagenicity Testing Application and Other Applications for the Years 2014, 2025 & 2030
  • TABLE 407: Africa Recent Past, Current & Future Analysis for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 408: Africa Historic Review for In-Vitro Toxicology Assays by Test Type - Cannabis Testing Type and Nicotine Testing Type Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 409: Africa 16-Year Perspective for In-Vitro Toxicology Assays by Test Type - Percentage Breakdown of Value Sales for Cannabis Testing Type and Nicotine Testing Type for the Years 2014, 2025 & 2030

IV. COMPETITION